-
November 17: Applied Cost-Effectiveness Modeling with R - In Person at ISPOR Europe 2024
-
November 17: Advanced Patient-Reported Outcomes - In Person at ISPOR Europe 2024
-
ISPOR Real-World Evidence Summit 2024
, BARCELONA | SPAIN
This summit will cover latest developments in use of real world evidence across regulatory-HTA-payer decision-making continuum with focus on methods, data transportability, and infrastructure. Major methods topics to be covered include causal inference and external control arms for comparative effectiveness analyses, the hierarchy of RWE studies, and the role of patient registries. Use of RWE in Joint Clinical Assessment of the EU HTA regulation will be explored, also with insights from the cross-border collaborations on pricing and reimbursement in the EU countries. Finally, feasibility of HTA reassessment post market entry will be considered, drawing from lessons learned from US Medicare Drug Price Negotiation.
-
December 4-5: Budget Impact Analysis II: Applications and Design Issues- Virtual
-
ISPOR 2025
, Montreal | QC, Canada
Join global healthcare leaders as they convene at ISPOR 2025, the leading global conference for Health Economics and Outcomes Research (HEOR) on May 13 - 16, for discussion and dissemination of the latest trends in healthcare. This must-attend event provides you with dedicated opportunities to network with your peers, HEOR experts, and thought leaders and to discuss with a global audience how we establish, incentivize, and share value sustainable for health systems, patients, and technology developers.